Israel Rozen

Insider Reports History

Entity
Individual
Location
500 Technology Square, Cambridge, MA
Signature
/s/ Andrew Ashe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Israel Rozen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verve Therapeutics, Inc. 10%+ Owner Common Stock 410K $4.1M $10.00 Jun 16, 2021 Direct

Insider Reports Filed by Israel Rozen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERV Verve Therapeutics, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 10%+ Owner